Home/Filings/4/0000914190-09-000742
4//SEC Filing

Howe Roger J 4

Accession 0000914190-09-000742

CIK 0001180145other

Filed

Nov 19, 7:00 PM ET

Accepted

Nov 20, 12:15 PM ET

Size

18.4 KB

Accession

0000914190-09-000742

Insider Transaction Report

Form 4
Period: 2009-11-18
Howe Roger J
Director
Transactions
  • Sale

    Common Stock

    2009-11-18$4.82/sh14,350$69,1440 total(indirect: By Partnership)
Holdings
  • Stock Option (right to buy)

    Exercise: $9.28From: 2004-12-01Exp: 2009-11-30Common Stock (12,940 underlying)
    12,940
  • Stock Option (right to buy)

    Exercise: $12.37From: 2005-12-01Exp: 2010-11-30Common Stock (9,705 underlying)
    9,705
  • Stock Option (right to buy)

    Exercise: $7.90From: 2007-10-09Exp: 2017-10-08Common Stock (4,321 underlying)
    4,321
  • Stock Option (right to buy)

    Exercise: $12.15From: 2007-12-31Exp: 2012-12-30Common Stock (121,490 underlying)
    121,490
  • Restricted Stock Units

    Common Stock (5,714 underlying)
    5,714
  • Restricted Stock Units

    Common Stock (11,628 underlying)
    11,628
  • Stock Option (right to buy)

    Exercise: $8.83From: 2006-12-19Exp: 2016-12-18Common Stock (12,940 underlying)
    12,940
  • Stock Option (right to buy)

    Exercise: $11.38From: 2007-11-13Exp: 2017-11-12Common Stock (15,088 underlying)
    15,088
  • Warrant

    (indirect: By Partnership)
    Exercise: $9.28From: 2005-10-25Exp: 2009-11-16Common Stock (8,411 underlying)
    8,411
Footnotes (4)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.81 to $4.84, inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.
  • [F2]Shares held by Sonora Web LLLP, of which Dr. Howe is the General Partner.
  • [F3]Each restricted stock unit represents the right to receive a payment from CSI equal in value to the market price per share of CSI common stock on the date of payment and shall be payable in cash beginning six months following the termination of each director's board membership.
  • [F4]Each restricted stock unit represents the right to receive a payment from CSI equal in value to the market price per share of CSI common stock on the date of payment, and shall be payable in cash beginning six months following the termination of each director's board membership; provided, however, that the restricted stock units vest in equal quarterly amounts of 2,907 on each of 9/30/2009, 12/31/2009, 3/31/2010 and 6/30/2010.

Issuer

Cardiovascular Systems Inc

CIK 0001180145

Entity typeother

Related Parties

1
  • filerCIK 0001428728

Filing Metadata

Form type
4
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 12:15 PM ET
Size
18.4 KB